Oramed Pharmaceuticals Inc. (ORMP)

NASDAQ: ORMP · Real-Time Price · USD

3.970

-0.200 (-4.80%)

At close: Jul 29, 2026, 4:00 PM EDT

3.930

-0.040 (-1.01%)

After-hours: Jul 29, 2026, 4:59 PM EDT

Oramed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	13.2	45.95	54.42	9.06	40.46	27.46
Short-Term Investments	52.64	84.58	87.51	152.99	115.26	118.82
Cash & Short-Term Investments	65.84	130.53	141.93	162.05	155.72	146.28
Cash Growth	-49.60%	-8.03%	-12.41%	4.06%	6.45%	55.39%
Other Current Assets	2.31	2.74	1.29	0.54	1.39	1.66
Total Current Assets	68.15	133.27	143.22	162.58	157.11	147.94
Net Property, Plant & Equipment	1.25	1.34	1.11	1.57	1.8	0.89
Long-Term Investments	199.4	96.21	10.91	56.37	2.7	3.88
Other Long-Term Assets	0.05	0.05	0.03	0.03	0.03	25.12
Total Assets	268.85	230.86	155.28	220.55	161.64	177.82

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	8.52	6.85	5.47	1.93	4.16	4.54
Short-Term Debt	-	-	-	51.01	-	-
Current Portion of Leases	0.27	0.29	0.22	0.27	0.25	0.13
Unearned Revenue	1.47	1.35	-	-	1.34	2.7
Other Current Liabilities	0.3	10.6	-	-	-	-
Total Current Liabilities	10.56	19.09	5.69	53.21	5.75	7.37
Long-Term Leases	0.49	0.54	0.16	0.34	0.65	0.37
Other Long-Term Liabilities	19.52	11.49	4.09	4.1	4.09	3.47
Total Long-Term Liabilities	20.01	12.03	4.25	4.44	4.74	3.84
Total Liabilities	30.57	31.12	9.93	57.66	10.49	11.21

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.49	0.47	0.48	0.49	0.48	0.46
Additional Paid-in Capital	322.91	322.71	322.4	320.89	314.42	292.51
Retained Earnings	-85.12	-123.44	-176.62	-157.56	-163.08	-126.52
Total Common Shareholders' Equity	238.28	199.74	146.27	163.82	151.81	166.45
Minority Interest	-	-	-0.92	-0.93	-0.66	0.16
Shareholders' Equity	238.28	199.74	145.35	162.89	151.16	166.61
Total Liabilities & Equity	268.85	230.86	155.28	220.55	161.64	177.82

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.76	0.83	0.37	51.62	0.89	0.5
Net Cash (Debt)	65.08	129.71	141.56	110.43	154.83	145.78
Net Cash Growth	-50.07%	-8.37%	28.19%	-28.68%	6.21%	55.74%
Net Cash Per Share	1.55	3.06	3.46	2.72	3.97	3.82
Book Value	238.28	199.74	146.27	163.82	151.81	166.45
Book Value Per Share	5.67	4.71	3.58	4.04	3.89	4.36
Tangible Book Value	238.28	199.74	146.27	163.82	151.81	166.45
Tangible Book Value Per Share	5.67	4.71	3.58	4.04	3.89	4.36

SEC Filings: 10-K · 10-Q